Observational Study of Subjects Having Routine Recurrence Screening for Bladder Cancer

Predictive Biosciences

Status: Completed

Conditions: Bladder Cancer Recurrence

Study type: Observational

Funder types: Industry

Identifiers

NCT00903240

PBS-001

Details and patient eligibility

About

The purpose of this study is to detect recurrent bladder cancer using a combination of protein and DNA biomarkers in urine

Enrollment: 1,000 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Intact bladder
• Scheduled for cystoscopy for transitional cell bladder cancer recurrence screening
• Urine donated prior to cystoscopy, Bladder biopsy, chemotherapy, intravesical therapy, radiation or TUR
• Must be willing to sign IRB approved informed consent

Exclusion criteria

• History or current diagnosis of any cancer except transitional cell bladder cancer or basal cell cancer
• Known diagnosis of any autoimmune disease or HIV, HCV or HBV
• History or current TB or any other active infection
• Subject has gross hematuria
• Receiving chemotherapy, intravesical therapy or radiation within 30 days of enrollment
• Any surgery except urologic within past 30 days